Epilepsy clinical trials at UC Davis

1 research study open to eligible people

Showing trials for

  • Randomized Therapy In Status Epilepticus

    open to eligible people ages 12 years and up

    This study will evaluate the effectiveness and safety of an investigational product (IP), intravenous (IV) ganaxolone, to treat participants with status epilepticus (SE).

    Sacramento, California and other locations